A recent study demonstrated that treatment of hyperactive mice with psychostimulants and serotonergic agents produced a calming effect that was dependent on serotonergic neurotransmission and was not associated with any changes in extracellular dopamine levels.
A recent study demonstrated that treatment of hyperactive mice with psychostimulants and serotonergic agents produced a calming effect that was dependent on serotonergic neurotransmission and was not associated with any changes in extracellular dopamine levels. 1 The complex interaction between the serotonergic and dopaminergic neurotransmitter systems suggests that a balance between the two systems may be necessary for mediating hyperactive behaviour. Defects in serotonin system genes, therefore, may disrupt normal brain serotonin function causing an imbalance between these neurotransmitter systems leading to the development of attention deficit hyperactivity disorder (ADHD). Attention deficit hyperactivity disorder (ADHD) is a common childhood disruptive behavioral disorder affecting between 3-5% of school age children who display persistent patterns of inattention and hyperactivity/impulsivity causing impairment in academic, social, and emotional development.
Using the transmission disequilibrium test (TDT)
2 ADHD children frequently exhibit a variety of other comorbid conditions such as learning disorder, mood disorder, and other disruptive behavior disorders including oppositional defiant disorder (ODD) and conduct disorder (CD).
While the exact mechanisms for the disorder are unknown, research has suggested abnormalities in the catecholaminergic and serotonergic systems. Support for a catecholaminergic hypothesis has been based on evidence from neuroimaging studies which have suggested reduced functioning in frontal-striatal regions, whose pathways are rich in catecholamines, notably dopamine. 3 Furthermore, stimulant medications, such as methylphenidate (Ritalin™), whose primary site of action is the dopamine transporter, have shown widespread clinical success in the treatment of ADHD. The significant interaction between the dopaminergic and serotonergic systems, 4 however, suggests that dopamine dysfunction may not be the sole basis for the development of ADHD.
Evidence for the serotonergic hypothesis began two decades ago when it was found that whole blood and serum serotonin (5-HT) concentrations were decreased in children with ADHD. 5, 6 These results have been further supported by a recent study that also found a tendency towards low platelet serotonin in a sample of children with severe ADHD. 7 Additional support for a serotonin hypothesis is demonstrated by the moderate efficacy of several serotonin enhancing agents in the treatment of ADHD including selective serotonin reuptake inhibitors (SSRIs) 8 and certain selective monoamine oxidase inhibitors. 9 Several lines of evidence have indicated abnormal serotonergic function in children with disruptive behaviour disorders (ADHD, ODD, CD) who display marked problems with hyperactivity, impulsivity, and aggression. [10] [11] [12] [13] [14] Animal models of ADHD have also been useful in implicating a role for serotonin in the control of attention, impulsivity, and hyperactivity. Rodents that had poorer performance on a task measuring attention and impulsivity had a greater index of serotonin utilization in the frontal cortex. 15 Perhaps the most notable evidence linking serotonin to ADHD was shown recently in a study of a mouse model of hyperactivity. 1 In this study the researchers developed homozygous dopamine transporter knockout mice (DAT-KO), which resulted in hyperactive behavior apparently due to high levels of extracellular dopamine in the absence of the dopamine transporter. Treatment of these mice with both psychostimulants and several serotonergic drugs produced a calming effect in the KO mice that was independent of any changes in extracellular levels of dopamine in the striatum. These results suggested that a different mechanism must be involved in response to these drugs in the DAT-KO mice, causing the reduction in hyperactivity. This led to the conclusion that serotonin neurotransmission mediated motor activity alterations in the mice while extracellular dopamine concentration remained unchanged.
Several adoption, family, and twin studies have suggested a strong heritable component in ADHD and its co-existing psychiatric disorders. [16] [17] [18] [19] [20] To date, molecular genetics research in ADHD has focused primarily on the role of the dopamine system with several studies having shown positive associations of polymorphisms in dopamine system genes with ADHD. [21] [22] [23] [24] The existing literature surrounding the dopamine hypothesis of ADHD and the accumulating neurobiological evidence pointing towards a role for the serotonin system, leads to the hypothesis that a balance between the dopamine and serotonin systems is necessary for mediating behaviors such as attention, hyperactivity and impulsivity. It is possible, therefore, that defects in serotonin system genes may disrupt normal brain serotonin function leading to an imbalance between these neurotransmitter systems. This rationale argues that in addition to dopamine system genes, genes involved in serotonin neurotransmission, are also likely candidates for molecular genetic studies of ADHD.
The serotonin HTR2A gene, located on chromosome 13q14-q21, 25 codes for a G protein-coupled receptor functioning in signal transduction mediated via phosphoinositol (PI) hydrolysis and intracellular Ca 2+ mobilization. 26 Antagonism of 5-HT2A receptors has been shown to reduce dopamine-induced hyperactivity in mice, 27 providing support for the interaction of serotonergic and dopaminergic systems in mediating hyperactive behaviour. In the current study we tested for linkage disequilibrium of two HTR2A polymorphisms, His 452 Tyr 28, 29 and T102C 30 with ADHD using the transmission disequilibrium test (TDT).
All family members including available parents, probands, and affected siblings were genotyped for the HTR2A T102C and His
452
Tyr polymorphisms. Of the 115 families included in this study, 93 families had genotypes available from both parents and the remaining 22 families had genotypes available from one parent. Of the total of 143 affected cases meeting DSM-IV criteria for ADHD, 57% of the children were combined type (CT), 19% were hyperactive/impulsive type (HIT), and 24% were primarily inattentive type (PIT). In addition, 39% of the children were diagnosed with comorbid ODD, and 11% with comorbid CD. Allele frequencies in unrelated parents in our sample were in accordance with previous studies (Table 1) . 28, 29 TDT transmission data for alleles at the HTR2A T102C and His 452 Tyr polymorphisms can be seen in Table 1 . Under the null hypothesis of random transmission of alleles, TDT results for the HTR2A His 452 Tyr polymorphism provided evidence for preferential (Table 2) .
Results from the TDT analysis provided evidence for linkage disequilibrium between the 452 Tyr allele of the HTR2A His 452 Tyr polymorphism and ADHD. These results must be interpreted cautiously as the number of informative transmissions was modest, leading to a possible spurious finding. In contrast, there was no evidence for biased transmission of alleles of the T102C polymorphism to ADHD probands. Furthermore, no HTR2A haplotype combination of these alleles demonstrated linkage disequilibrium with ADHD. This was not surprising given that the level of linkage disequilibrium between the two markers was very low, indicating that T102C and His 45 Tyr are essentially independent of one another.
The His 452 Tyr polymorphism causes an amino acid substitution from histidine to tyrosine at position 452 31 It is possible therefore that linkage of the 452 Tyr variant with ADHD in our sample may be a result of differences in 5-HT2A receptor function leading to behavioral variation. Several lines of evidence have implicated the involvement of the striatal 5-HT2A receptors in mediating stimulant-induced dopamine release 32, 33 and hyperactivity. 27, 34 For example, selective 5-HT2A antagonists have been shown to attenuate the hyperlocomotor effects of amphetamine and cocaine apparently by inhibiting the increase in dopamine release that causes hyperactivity. 27 In other words, activation of the 5-HT2A receptor is necessary for mediating the effects of dopamine enhancing agents. However, results from electrophysiological studies have shown that stimulation of serotonergic neurons, originating in the dorsal raphe, play an inhibitory role on the dopamine system. In the midbrain, projections to the substantial nigra inhibit the firing of dopamine neurons, while in the striatum and cortex they inhibit synaptic dopamine release and synthesis. 35 Furthermore, this inhibitory effect appears to be mediated via 5-HT2A receptors located on the dopaminergic neuron, such that antagonism of the receptor releases the dopamine system from inhibition. Based on the evidence demonstrating the role of the 5-HT2A receptor in mediating interaction between the serotonergic and dopaminergic systems, it would seem feasible that DNA variants in genes that affect serotonin receptor gene function, namely the HTR2A gene, may indirectly modify dopamine function leading to ADHD.
In conclusion, our results, although preliminary, are the first to suggest a possible role for a serotonin system gene in ADHD. Certainly more studies are needed and the findings replicated before firm conclusions can be made. The results of this study should be considered preliminary in light of the significance level of these findings and that we have tested other candidate genes in this sample and have not corrected for multiple testing. Based on the existing literature and the complex interaction among neurotransmitter systems, it is important not to limit the scope of molecular genetic research to one major system (eg dopamine) and to consider the possibility of several systems being involved. ADHD is a complex, heterogeneous disorder presenting itself in various behavioral dimensions including inattention, hyperactivity, and impulsivity, often co-occurring with other behaviour problems as seen in children with comorbid ODD and CD. It is likely that different genes within different neurotransmitter systems have varying degrees of influence over these behavioral dimensions. This may open a new door in ADHD molecular genetics research, expanding the existing view of a catecholaminergic hypothesis to include a seroMolecular Psychiatry tonergic hypothesis and should help elucidate the complex interplay among the neurotransmitter systems in the etiology of ADHD.
Methods

Subjects
The sample consisted of 115 families containing probands between the ages of 7 and 16 who were referred to the Hospital for Sick Children in Toronto, Ontario for the clinical assessment of attention, behavior and learning problems. Twenty-four of these families consisted of one affected sibling in addition to the proband, and two families consisted of two affected siblings in addition to the proband, for a total sample of 143 children who met DSM-IV criteria for ADHD. One hundred and twelve of these children were males and 31 were females. The majority of families (94%) included in this study were of mixed European Caucasian descent describing themselves as English, Scottish, Irish, German, Italian, Polish, and Dutch. The remaining 6% of families were of mixed or non-Caucasian decent including African Canadian and Native Canadian. All participants gave informed written consent and the protocol was approved by the Hospital Research Ethics Board. 42 ). Children were included if they met DSM-IV criteria for one of the three ADHD subtypes (inattentive, hyperactive/impulsive, combined) and were excluded if they scored below 80 on both the Performance and Verbal Scales of the WISC-III, had evidence of neurological or complex medical illness, Tourette syndrome, chronic multiple tics, bipolar affective disorder, psychotic symptoms, or had comorbid anxiety, depressive or developmental disorder that could better account for the behaviors (as specified by DSM-IV). Children were free of medication for 24 h when assessed.
Diagnostic instruments
Genotyping
The high salt extraction method of Miller and colleagues 43 was used to isolate DNA from whole blood lymphocytes. The HTR2A T102C polymorphism was amplified using a modified protocol of Warren et al.
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A 25-l PCR reaction mixture containing 150 ng of genomic DNA, 0.8 M each of forward 5Ј TCT GCT ACA AGT TCT GGC TT-3Ј and reverse 5Ј-CTG CAG CTT TTT CTC TAG GG-3Ј primers, 1 × PCR buffer (10 mM Tris-HCl, 50 mM KCl), 2.5 mM MgCl 2 , 0.2 mM dNTPs, and 1 U Taq polymerase was used to amplify a 342-bp DNA fragment. PCR conditions consisted of an initial 3-min denaturation followed by 35 cycles of a 30-s denaturation at 94°C, 30 s annealing at 61°C, and a 30-s extension at 72°C, ending with a final 7-min extension at 72°C. The amplified product was digested with MspI at 37°C overnight, followed by electrophoresis on a 2.5% agarose gel at 100 V for 1 h to yield fragments of 216 bp and 126 bp in the presence of the 102T allele, or the single uncut fragment in the presence of the 102C allele.
The HTR2A His 452 Tyr polymorphism was amplified using the PCR protocol of Ozaki et al. 28 Forward 5Ј-CAC ACA GCT CAC CTT TTC ATT CA-3Ј and reverse 5Ј-AGT CTA GCC AAC TTC AAA TGG-3Ј primers were used to amplify a 155-bp product which was subsequently digested with BsmI at 65°C for 4 h and electrophoresed on a 3.5% agarose gel at 100 V for 1 h. The presence of the common 452 His allele yielded two fragments of 95 bp and 60 bp while the 452 Tyr allele produced the single uncut fragment.
Statistical methods
Following genotype assignment, statistical analysis was performed using the extended transmission disequilibrium program (ETDT version 1.8). 44 We used the TDT to assess for non-random transmission of alleles from heterozygous parents to an affected offspring by comparing the frequency of transmitted alleles to nontransmitted alleles. TDT analysis of HTR2A T102C and His 452 Tyr marker haplotypes was analyzed using the program Transmit Version 2.5. 45 Linkage disequilibrium among marker haplotypes in the HTR2A gene was assessed using the Equilibrium Haplotype (EH) linkage utility program. 46 
